시장보고서
상품코드
1701098

세계의 조직 절편 시장 규모, 점유율, 성장 분석 : 제품별, 기술별, 재료 유형별, 용도별, 최종 용도별, 지역별 - 산업 예측(2025-2032년)

Tissue Sectioning Market Size, Share, and Growth Analysis, By Product (Instruments, Accessories & Consumables), By Technology (Automatic, Semiautomatic), By Material Type, By Application, By End-Use, By Region - Industry Forecast 2025-2032

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 219 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 조직 절편 시장 규모는 2023년 5억 9,486만 달러로 평가되었고, 예측 기간(2025-2032년) 동안 10.8%의 연평균 복합 성장률(CAGR)로 2024년 6억 5,910만 달러에서 2032년 14억 9,718만 달러로 성장할 것으로 예측됩니다.

조직 절편 시장은 헬스케어 및 생명과학 분야에서 매우 중요하며, 연구, 진단 및 치료 전략의 발전을 촉진합니다. 주요 동향은 암과 신경 질환과 같은 만성 질환의 발병률 증가에 힘입어 견조한 성장세를 보이고 있습니다. 조직 절편은 얇은 조직 샘플을 정밀하게 검사할 수 있어 병리조직학 및 분자생물학의 응용을 지원하며, 이는 질병 진행을 이해하고 치료 효과를 평가하는 데 필수적입니다. 특히 자동화된 하이스루풋 시스템의 혁신은 정확성과 효율성을 높이고 잠재적인 진단 오류를 최소화하는 데 기여하고 있습니다. 또한, 개인 맞춤형 의료와 정밀 진단에 대한 수요가 증가함에 따라 정밀 조직 분석의 중요성이 높아지면서 맞춤형 치료 계획을 수립하고 환자의 치료 결과를 개선하는 데 조직 절편이 필수적인 역할을 하고 있습니다.

목차

서론

  • 조사 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차와 1차 데이터 방법
  • 시장 규모 예측
  • 시장 전제조건과 제한

주요 요약

  • 세계 시장 전망
  • 공급과 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • Porter의 Five Forces 분석

주요 시장 인사이트

  • 중요 성공 요인
  • 경쟁 정도
  • 주요 투자 기회
  • 시장 생태계
  • 시장의 매력 지수(2024년)
  • PESTEL 분석
  • 거시경제 지표
  • 밸류체인 분석
  • 가격 분석
  • 규제 상황
  • 특허 분석

조직 절편 시장 규모 : 제품별

  • 시장 개요
  • 기기
    • 회전식 마이크로톰
    • 슬라이딩 마이크로톰
    • 울트라 마이크로톰
    • 크라이오스탯
    • 기타
  • 액세서리 및 소모품
  • 서비스

조직 절편 시장 규모 : 기술별

  • 시장 개요
  • 자동
  • 반자동
  • 수동

조직 절편 시장 규모 : 재료 유형별

  • 시장 개요
  • 파라포름알데히드
  • OCT 콤파운드
  • 포르말린
  • 임베딩 미디어

조직 절편 시장 규모 : 용도별

  • 시장 개요
  • 진단
  • 연구

조직 절편 시장 규모 : 최종 용도별

  • 시장 개요
  • 병원
  • 클리닉
  • 진단실험실
  • 연구센터

조직 절편 시장 규모

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 주요 5개사 비교
  • 주요 기업의 시장 포지셔닝(2024년)
  • 주요 시장 기업이 채택한 전략
  • 최근 시장 동향
  • 기업의 시장 점유율 분석(2024년)
  • 주요 기업 개요
    • 기업 상세
    • 제품 포트폴리오 분석
    • 기업 부문별 점유율 분석
    • 매출 전년대비 비교(2022-2024년)

주요 기업 개요

  • Thermo Fisher Scientific Inc.(USA)
  • Leica Biosystems(USA)
  • Sakura Finetek USA, Inc.(USA)
  • Agilent Technologies, Inc.(USA)
  • Merck KGaA(Germany)
  • Roche Diagnostics(Switzerland)
  • CellPath Ltd(UK)
  • Gilson Incorporated(USA)
  • RMC Boeckeler(USA)
  • SLEE medical GmbH(Germany)
  • MEDITE GmbH(Germany)
  • Jinhua YIDI Medical Appliance Co., Ltd.(China)
  • Diapath S.p.A.(Italy)
  • Hacker Instruments & Industries Inc.(USA)
  • Bright Instrument Company td(UK)
  • Boeckel+Co(GmbH+Co) KG(Germany)
  • MICROS Produktions-und Handelsgesellschaft m.b.H(Austria)
  • Nanolytik GmbH(Germany)
  • Microservice S.r.l.(Italy)
  • Screen Holdings Co., Ltd.(Japan)

결론과 제안

LSH 25.05.21

Global Tissue Sectioning Market size was valued at USD 594.86 million in 2023 and is poised to grow from USD 659.1 million in 2024 to USD 1497.18 million by 2032, growing at a CAGR of 10.8% during the forecast period (2025-2032).

The Tissue Sectioning Market is crucial to healthcare and life sciences, driving advancements in research, diagnostics, and treatment strategies. Key trends indicate robust growth, primarily fueled by the rising incidence of chronic diseases, including cancer and neurological disorders. Tissue sectioning enables detailed examination of thin tissue samples, supporting applications in histopathology and molecular biology, vital for understanding disease progression and evaluating treatment efficacy. Technological innovations, particularly in automated and high-throughput systems, are enhancing accuracy and efficiency, minimizing potential diagnostic errors. Moreover, as the demand for personalized medicine and precision diagnostics grows, the importance of precise tissue analysis escalates, solidifying tissue sectioning's integral role in developing tailored treatment plans and improving patient care outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue Sectioning market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tissue Sectioning Market Segments Analysis

Global Tissue Sectioning Market is segmented by Product, Technology, Material Type, Application, End-Use and region. Based on Product, the market is segmented into Instruments, Accessories & Consumables and Services. Based on Technology, the market is segmented into Automatic, Semiautomatic and Manual. Based on Material Type, the market is segmented into Paraformaldehyde, OCT Compound, Formalin and Embedding Media. Based on Application, the market is segmented into Diagnosis and Research. Based on End-Use, the market is segmented into Hospitals, Clinics, Diagnostic Laboratories and Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Tissue Sectioning Market

The increasing incidence of chronic illnesses, including cancer, cardiovascular diseases, and neurological disorders, has emerged as a major catalyst for the growth of the global tissue sectioning market. This essential technique in pathology and research plays a vital role in the diagnosis and comprehension of these medical conditions. With an aging global population and a corresponding rise in the prevalence of chronic diseases, there is a surging demand for tissue sectioning tools and services. Consequently, the tissue sectioning market is experiencing substantial growth, driven by the urgent need for precise diagnostic methods to address these health challenges.

Restraints in the Global Tissue Sectioning Market

The Global Tissue Sectioning market faces notable constraints primarily due to the high costs associated with advanced automated tissue sectioning equipment. This financial burden can deter smaller laboratories, clinics, and research institutions that operate on tight budgets from investing in such technology. The substantial initial expenses related to both the purchase and maintenance of these advanced systems can obstruct their widespread adoption, particularly in environments with limited financial resources. Consequently, the financial barriers presented by the pricing of tissue sectioning equipment may hinder technological advancements and limit access to quality tissue sectioning solutions in various healthcare and research settings.

Market Trends of the Global Tissue Sectioning Market

The Global Tissue Sectioning market is witnessing a transformative shift driven by the automation and digitization of tissue sectioning processes. Automated equipment, including advanced microtomes and cryostats, significantly enhances workflow efficiency and precision, thereby minimizing cross-contamination risks. This increase in automation is complemented by a notable trend towards digitizing tissue samples, fostering improved storage, analysis, and interoperability among pathology laboratories. The rise of digital pathology systems, integrated with sophisticated image analysis software, is making it easier for researchers and clinicians to access and interpret tissue data, ultimately propelling advancements in diagnostics and personalized medicine within a fast-evolving marketplace.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Patent Analysis

Global Tissue Sectioning Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Instruments
    • Rotary Microtome
    • Sliding Microtome
    • Ultramicrotome
    • Cryostat
    • Others
  • Accessories & Consumables
  • Services

Global Tissue Sectioning Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Automatic
  • Semiautomatic
  • Manual

Global Tissue Sectioning Market Size by Material Type & CAGR (2025-2032)

  • Market Overview
  • Paraformaldehyde
  • OCT Compound
  • Formalin
  • Embedding Media

Global Tissue Sectioning Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Diagnosis
  • Research

Global Tissue Sectioning Market Size by End-Use & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Research Centers

Global Tissue Sectioning Market Size & CAGR (2025-2032)

  • North America (Product, Technology, Material Type, Application, End-Use)
    • US
    • Canada
  • Europe (Product, Technology, Material Type, Application, End-Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Technology, Material Type, Application, End-Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Technology, Material Type, Application, End-Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Technology, Material Type, Application, End-Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Leica Biosystems (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sakura Finetek USA, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CellPath Ltd (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gilson Incorporated (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RMC Boeckeler (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SLEE medical GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MEDITE GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jinhua YIDI Medical Appliance Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Diapath S.p.A. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hacker Instruments & Industries Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bright Instrument Company td (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boeckel + Co (GmbH + Co) KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MICROS Produktions- und Handelsgesellschaft m.b.H (Austria)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nanolytik GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Microservice S.r.l. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Screen Holdings Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제